Abstract:Microneedle-based drug delivery offers an attractive and minimally invasive administration route to deliver therapeutic agents through the skin by bypassing the stratum corneum, the main skin barrier. Recently, hydrogel-based microneedles have gained prominence for their exceptional ability to precisely control the release of their drug cargo. In this study, we investigated the feasibility of fabricating microneedles from triblock amphiphiles with linear poly(ethylene glycol) (PEG) as the hydrophilic middle block and two dendritic side-blocks with enzyme-cleavable hydrophobic end-groups. Due to the poor formation and brittleness of microneedles made from the neat amphiphile, we added a sodium alginate base layer and tested different polymeric excipients to enhance the mechanical strength of the microneedles. Following optimization, microneedles based on triblock amphiphiles were successfully fabricated and exhibited favorable insertion efficiency and low height reduction percentage when tested in Parafilm as a skin-simulant model. When tested against static forces ranging from 50 to 1000 g (4.9-98 mN/needle), the microneedles showed adequate mechanical strength with no fractures or broken segments. In buffer solution, the solid microneedles swelled into a hydrogel within about 30 s, followed by their rapid disintegration into small hydrogel particles. These hydrogel particles could undergo slow enzymatic degradation to soluble polymers. In vitro release study of dexamethasone (DEX), as a steroid model drug, showed first-order drug release, with 90% released within 6 days. Eventually, DEX-loaded MNs were subjected to an insertion test using chicken skin and showed full penetration. This study demonstrates the feasibility of programming hydrogel-forming microneedles to undergo several mesophase transitions and their potential application as a delivery system for self-administration, increased patient compliance, improved efficacy, and sustained drug release.

Transdermal drug delivery using a porous microneedle device driven by a hydrogel electroosmotic pump

Transdermal electroosmotic flow generated by a porous microneedle array patch

An Ultra‐Swelling Microneedle Device for Facile And Efficient Drug Loading And Transdermal Delivery

P‐10.10: Wearable Transdermal Drug Delivery Devices based on Piezoelectric Micropumps Integrated with Microneedles Array

Bilaterally Aligned Electroosmotic Flow Generated by Porous Microneedle Device for Dual-Mode Delivery

Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery

Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery

Towards Micropump- and Microneedle-based Drug Delivery Using Micro Transdermal Interface Platforms (Microtips)

Self-Powered Intracellular Drug Delivery by a Biomechanical Energy-Driven Triboelectric Nanogenerator

Increased mechanical stability and permeability by filling the interconnected pores of porous microneedles

Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery

Ex vivo evaluation of a microneedle array device for transdermal application

Responsive Hydrogel Microcarrier‐Integrated Microneedles for Versatile and Controllable Drug Delivery

Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery

Porous Polymer Microneedles with Superhydrophilic Surface for Rapid Fluid Transport

Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing

Hydrogel-Based Microneedle as a Drug Delivery System

Self‐Healing Porous Microneedles Fabricated Via Cryogenic Micromoulding and Phase Separation for Efficient Loading and Sustained Delivery of Diverse Therapeutics

DESIGN, SIMULATION AND ANALYSIS OF MICRONEEDLES FOR TRANSDERMAL DRUG DELIVERY

Recent advances in porous microneedles: materials, fabrication, and transdermal applications

Punching and Electroporation for Enhanced Transdermal Drug Delivery